Tove Skjelbakken
Job description
Associate Professor, Institute of Community Medicine, University of Tromsø (20 % position)
Specialist in Internal medicine and Hematology
Tove Skjelbakken
:
Borte bra, men hjemme best
Trygve S. Ellingsen,
Jostein Lappegård,
Tove Skjelbakken,
Ellisiv B. Mathiesen,
Inger Njølstad,
Sigrid Kufaas Brækkan
et al.:
The association between red cell distribution width and venous thromboembolism is not explained by myocardial infarction, stroke, or cancer
Laila Arnesdatter Hopstock,
Elisabeth Bøe Utne,
Alexander Horsch,
Tove Skjelbakken
:
The association between anemia and falls in community-living women and men aged 65 years and older from the fifth Tromsø Study 2001-02: a replication study
Jostein Lappegård,
Trygve Ellingsen,
Tove Skjelbakken,
Ellisiv B. Mathiesen,
Inger Njølstad,
Tom Wilsgaard
et al.:
Red cell distribution width is associated with future risk of incident stroke: The Tromsø Study
Dag Torfoss,
Tone Fladhagen,
Harald Holte,
Lorentz Brinch,
Fredrik Hellem Schjesvold,
Yngvar Fløisand
et al.:
Benzylpenicillin plus an aminoglycoside versus meropenem in neutropenic lymphoma and leukaemia patients with a suspected bacterial infection: a randomized, controlled trial
Trygve Ellingsen,
Jostein Lappegård,
Tove Skjelbakken,
Sigrid Kufaas Brækkan,
John-Bjarne Hansen
:
Impact of red cell distribution width on future risk of cancer and all-cause
mortality among cancer patients – the Tromsø Study
Jostein Lappegård,
Trygve Ellingsen,
Anders Vik,
Tove Skjelbakken,
Jan Brox,
Ellisiv B. Mathiesen
et al.:
Red cell distribution width and carotid atherosclerosis progression: The tromsø study
Trygve Ellingsen,
Jostein Lappegård,
Tove Skjelbakken,
Sigrid Kufaas Brækkan,
John-Bjarne Hansen
:
Red cell distribution width is associated with incident venous thromboembolism (VTE) and case-fatality after VTE in a general population
Tove Skjelbakken,
Jostein Lappegård,
Trygve Ellingsen,
Elizabeth Barrett-Connor,
Jan Brox,
Maja-Lisa Løchen
et al.:
Red cell distribution width is associated with incident myocardial infarction in a general population: The tromsø study
Audhild Nyrnes,
Inger Njølstad,
Ellisiv B. Mathiesen,
Tom Wilsgaard,
John-Bjarne Hansen,
Tove Skjelbakken
et al.:
Inflammatory biomarkers as risk factors for future atrial fibrillation. An eleven-year follow-up of 6315 men and women: the Tromsø Study
Tove Skjelbakken,
inger marie Dahl,
Maja-Lisa Løchen
:
Changes in Body Mass Index and Smoking Habits Have a Different Impact on Hemoglobin Concentration in Men and Women: A Longitudinal Follow-Up of the Tromso Study, 1994-2002
Jon-Magnus Tangen,
Yngvar Fløisand,
Einar Haukås,
Inger Anne Næss,
Tove Skjelbakken,
Camilla I Stapnes
et al.:
Overlevelse hos voksne med akutt lymfoblastisk leukemi :
Lone Jørgensen,
Tove Skjelbakken,
Maja-Lisa Løchen,
Luai Ahmed,
Åshild Bjørnerem,
Ragnar M Joakimsen
et al.:
Anemia and the risk of non-vertebral fractures: the Tromso Study
H. Johnsen,
Anne Husebekk,
Tove Skjelbakken
:
Severe antibody-mediated agranulocytosis
Tove Skjelbakken,
Tom Wilsgaard,
Olav Helge Førde,
Egil Arnesen,
Maja-Lisa Løchen
:
Haemoglobin predicts total mortality in a general young and middle-aged male population. The Tromso Study
Scandinavian Journal of Clinical and Laboratory Investigation 2006 ARKIV
Tove Skjelbakken,
inger marie Dahl,
Tom Wilsgaard,
Bodil Langbakk,
Maja-Lisa Løchen
:
Changes in haemoglobin levels according to changes in body mass index and smoking habits, a 20-year follow-up of a male cohort - The Tromso Study 1974-1995
Tove Skjelbakken,
B Langbakk,
Inger Marie Dahl,
Maja-Lisa Løchen
:
Haemoglobin and anaemia in a gender perspective: The Tromso Study
European Journal of Haematology 2005 ARKIV
Tove Skjelbakken,
Kirsti Rakkenes,
Lars Mandelkow,
Marla Clayman,
Mirjam Lauritzen,
Anne Regine Lager
:
Stairway to SDM: Building a matrix to ensure the integration of shared decision making in a hospital
2023 ARKIV
Tove Skjelbakken,
Anne Regine Lager,
Elisabeth Sundkvist,
Kirsti Rakkenes,
Lars Mandelkow,
Margrethe Aase Schaufel
et al.:
Leserbrief zu “New status report from Norway: Implementation of patient involvement in Norwegian health care” (ZEFQ) 171 (2022) 105–112 von J. Kasper et al.
Therese Kristine Dalsbø,
Kristin Thuve Dahm,
Leif Arvid Øvernes,
Mirjam Lauritzen,
Tove Skjelbakken
:
Nytteverdien av behandling for voksne med primær psykose: dokumentasjonsgrunnlag for samvalgsverktøy
Therese Kristine Dalsbø,
Kristin Thuve Dahm,
Anna Klara Måseide,
Tove Skjelbakken
:
Nytteverdien av behandling for prostatakreft uten spredning: dokumentasjonsgrunnlag for samvalgsverktøy
Therese Kristine Dalsbø,
Kristin Thuve Dahm,
Tove Skjelbakken
:
Tidlig hormonbehandling mot prostatakreft med spredning gir trolig bedre resultat. Cochrane - kort oppsummert
Therese Kristine Dalsbø,
Kristin Thuve Dahm,
Kirsti Rakkenes,
Tove Skjelbakken
:
Nytteverdien av behandling for muskelknuter i livmor: dokumentasjonsgrunnlag for samvalgsverktøy
Therese Kristine Dalsbø,
Kristin Thuve Dahm,
Tove Skjelbakken
:
Gir tillegg av cellegift bedre effekt enn hormonbehandling alene mot prostatakreft med spredning? Cochrane - Kort oppsummert
Lone Jørgensen,
Tove Skjelbakken,
Maja-Lisa Løchen,
Luai A. Ahmed,
Åshild Bjørnerem,
Ragnar M Joakimsen
et al.:
Anemia and the risk of non-vertebral fractures
Tove Skjelbakken
:
Haemoglobin, anaemia and haematological malignancies
Universitetet i Tromsø 2006 ARKIV
The 50 latest publications is shown on this page. See all publications in Cristin here →
Research interests
Clinical communication
Shared decision making
Global health
Epidemiology
Haematology
Quality and safety in health
CV
Previous academic positions